CHRO — ChromoGenics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK30.36m
- SEK89.25m
- SEK13.65m
Annual cashflow statement for ChromoGenics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -74.9 | -56.8 | -59.7 | -55.9 | -48.7 |
| Depreciation | |||||
| Non-Cash Items | -2.96 | -4.11 | -3.88 | -0.919 | -0.16 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.37 | 6.15 | 2.5 | -5.84 | 4.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -61.6 | -49.7 | -58.8 | -59.3 | -40.8 |
| Capital Expenditures | -69 | -20.7 | -16 | -4.93 | -0.136 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.15 | 0.04 | 0 | 0.038 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -68.8 | -20.6 | -16 | -4.89 | -0.136 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 148 | 139 | 0.204 | 69.5 | 24.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.3 | 68.5 | -74.5 | 5.28 | -16.2 |